Clinical Trial Update: Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in HCV-infected Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating daclatasvir plus sofosbuvir in children with hepatitis C virus infection, focusing on pharmacokinetics, safety, efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daclatasvir plus Sofosbuvir

Snippet

Sponsor: Ain Shams University | Conditions: HCV | Phase 3 | Status: UNKNOWN